Drug Shortage Report for MIDAZOLAM INJECTION

Last updated on 2021-10-22 History
Report ID 144789
Drug Identification Number 02242904
Brand name MIDAZOLAM INJECTION
Common or Proper name Midazolam Injection 1 mg/mL MD Vial 5 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MIDAZOLAM
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 mL
ATC code N05CD
ATC description HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-09-01
Actual start date
Estimated end date 2021-11-01
Actual end date 2021-10-21
Shortage status Resolved
Updated date 2021-10-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2021-10-22 English Compare
v10 2021-10-21 French Compare
v9 2021-10-21 English Compare
v8 2021-10-01 French Compare
v7 2021-10-01 English Compare
v6 2021-10-01 English Compare
v5 2021-09-15 French Compare
v4 2021-09-15 English Compare
v3 2021-09-02 English Compare
v2 2021-08-27 French Compare
v1 2021-08-27 English Compare

Showing 1 to 11 of 11